Home › ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial
 

Keywords :   


ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial

2015-07-01 08:22:45| drugdiscoveryonline Home Page

ABL, Inc. (ABL), a contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the successful aseptic formulation and fill of an Ebola vaccine candidate for Emergent BioSolutions Inc. (EMERGENT)

Tags: product trial drug successfully

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.05Is Zimbabwe zigzagging into further currency chaos?
05.05Why mortgage rates are going up, not down
04.05This Week in Agribusiness, May 4, 2024
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
More »